PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:13 AM ET

Sponsor Check › Person

AW
No photo found yet (own website and image search run after this page is viewed)

Ajay Wakhloo

Named as an officer, director or promoter on SEC Form D filings · FL · Jan 5, 2015 → Apr 15, 2026

4deals (issuers)
$13.4Mreported sold
134investors
20Form D filings
2015–2026years on file

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:16 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Ajay Wakhloo is listed as an executive officer and director on 20 SEC Form D filings by 4 issuers between Jan 2015 and Apr 2026: Prometheus Therapeutics Inc. (Miramar, FL — other health care — 2020–2026; $8.18M reported sold to 46 investors), Deinde Medical Corp. (Miramar, FL — other health care — 2019–2025; $2.68M reported sold to 35 investors), NeuroFine Corp. (Miramar, FL — other health care — 2021–2026; $1.62M reported sold to 38 investors) and InNeuroCo, Inc. (Sunrise, FL — other health care — 2015–2017; $925K reported sold to 15 investors).

What this means A repeat sponsor — 4 separate companies raised money with this person listed as executive officer and director, over about 11 years. Across those companies the filings report $13.4M sold in total.

Listed alongside Marc Litzenberg (18 shared filings), John McEleney (12 shared filings), Bernie Navarro (11 shared filings), Baruch Lieber (7 shared filings), Bernardo Navarro (6 shared filings) and 6 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Ajay. Each name links to their own page.

3 of the issuers belong to the sponsor group Deinde (3 issuers, $3.98M reported sold, 2019–2026).

What this means A sponsor group is one team that sets up a new company for each deal. Deinde has 3 companies on file and $3.98M reported sold in total — the group page shows the whole track record in one place.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.

What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.

We compared 20 public filings for Ajay Wakhloo and found 11 differences, 3 worth asking the sponsor about: Paid seller listed without a CRD number: Andrew Bazarian; Paid seller listed without a CRD number: Christopher Lear; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Ajay Wakhloo has not run yet — it is joining a line of 9,986 names; searches run around the clock at the hosts' allowed rate. Searched so far: 27 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:16 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Ajay Wakhloo..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:16 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

11 differences found between the filings for Ajay Wakhloo — 3 worth asking about (compared 20 filings on Oct 24, 2026)

Worth asking · Jun 21, 2024

Paid seller listed without a CRD number: Andrew Bazarian — Prometheus Therapeutics Inc.

Andrew Bazarian is listed as receiving sales compensation on 1 filing (Jun 21, 2024) with no FINRA CRD number given.

What this means People paid to sell securities normally hold a FINRA registration with a CRD number. Without one we cannot look them up on BrokerCheck. Ask who they are and whether they are registered.

Sources
Worth asking · Jun 21, 2024

Paid seller listed without a CRD number: Christopher Lear — Prometheus Therapeutics Inc.

Christopher Lear is listed as receiving sales compensation on 1 filing (Jun 21, 2024) with no FINRA CRD number given.

What this means People paid to sell securities normally hold a FINRA registration with a CRD number. Without one we cannot look them up on BrokerCheck. Ask who they are and whether they are registered.

Sources
Worth asking · Jun 21, 2024

Paid seller listed without a CRD number: Elliot Sax — Prometheus Therapeutics Inc.

Elliot Sax is listed as receiving sales compensation on 1 filing (Jun 21, 2024) with no FINRA CRD number given.

What this means People paid to sell securities normally hold a FINRA registration with a CRD number. Without one we cannot look them up on BrokerCheck. Ask who they are and whether they are registered.

Sources
Note · Dec 19, 2014 – Apr 8, 2026

4 Form Ds were filed more than 15 days after the first sale

Form D filed 16 days after the first sale — NeuroFine Corp. · Form D filed 16 days after the first sale — Deinde Medical Corp. · Form D filed 21 days after the first sale — NeuroFine Corp. · Form D filed 17 days after the first sale — InNeuroCo, Inc.

What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.

Sources
Note · Sep 13, 2023 – Mar 20, 2025

Ajay Wakhloo's role changed at NeuroFine Corp.: director → executive officer, director

The Sep 13, 2023 filing lists Ajay Wakhloo as director; the Mar 20, 2025 Form D lists executive officer, director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Sources
Note · Nov 27, 2019 – Oct 15, 2021

Ajay Wakhloo's role changed at Deinde Medical Corp.: executive officer, director → director

The Nov 27, 2019 filing lists Ajay Wakhloo as executive officer, director; the Oct 15, 2021 Form D lists director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Sources
Note · Nov 12, 2025 – Apr 15, 2026

Offering amount changed between filings — Prometheus Therapeutics Inc.

The Nov 12, 2025 filing says $5,000,000 offered; the Apr 15, 2026 Form D/A says $6,500,000.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Sources
Note · Nov 9, 2023 – Feb 11, 2025

Offering amount changed between filings — Deinde Medical Corp.

The Nov 9, 2023 filing says $1,000,000 offered; the Feb 11, 2025 Form D/A says $2,000,000.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Sources
Note · Apr 12, 2024 – Jun 21, 2024

Offering amount lowered between filings — Prometheus Therapeutics Inc.

The Apr 12, 2024 filing says $8,375,000 offered; the Jun 21, 2024 Form D/A says $8,372,387.

What this means The target raise got smaller. That can mean the plan shrank or the sponsor stopped early. Ask what changed in the deal.

Sources
Note · Dec 19, 2014 – Sep 3, 2025

12 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — NeuroFine Corp. (latest filing Sep 3, 2025) · No amendment in the last 12 months on an offering that may still be open — NeuroFine Corp. (latest filing Mar 20, 2025) · No amendment in the last 12 months on an offering that may still be open — Deinde Medical Corp. (latest filing Feb 11, 2025) · No amendment in the last 12 months on an offering that may still be open — Prometheus Therapeutics Inc. (latest filing Jun 21, 2024) · No amendment in the last 12 months on an offering that may still be open — NeuroFine Corp. (latest filing Sep 13, 2023) · and 7 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Sources
Note · Jun 25, 2015 – Nov 12, 2025

4 address changes between filings

Address moved from Pembroke Pines, FL to Miramar, FL — Prometheus Therapeutics Inc. · Address moved from Pembroke Pines, FL to Miramar, FL — NeuroFine Corp. · Address moved from Miramar, FL to Pembroke Pines, FL — NeuroFine Corp. · Address moved from Miami Beach, FL to Sunrise, FL — InNeuroCo, Inc.

What this means Businesses move. If you were told one city and the forms say another, ask which is current.

Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

0 of 16 offerings report sales commissions; 1 reports finder's fees totalling $250,000; 0 report proceeds to related persons.

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Apr 15, 2026 D/A
Prometheus Therapeutics Inc.
File 021-563714
$0$0$0None listed on this filingEDGAR ↗
Apr 8, 2026 D
NeuroFine Corp.
File 021-579451
$0$0$0None listed on this filingEDGAR ↗
Nov 12, 2025 D
Deinde Medical Corp.
File 021-563715
$0$0$0None listed on this filingEDGAR ↗
Sep 3, 2025 D
NeuroFine Corp.
File 021-556469
$0$0$0None listed on this filingEDGAR ↗
Mar 20, 2025 D
NeuroFine Corp.
File 021-541526
$0$0$0None listed on this filingEDGAR ↗
Feb 11, 2025 D/A
Deinde Medical Corp.
File 021-496934
$0$0$0None listed on this filingEDGAR ↗
Jun 21, 2024 D/A
Prometheus Therapeutics Inc.
File 021-473344
$0$250,000$0Andrew Bazarian no CRD number reported
Christopher Lear no CRD number reported
Elliot Sax no CRD number reported
EDGAR ↗
Sep 13, 2023 D
NeuroFine Corp.
File 021-492023
$0$0$0None listed on this filingEDGAR ↗
Jul 26, 2022 D
Prometheus Therapeutics Inc.
File 021-453702
$0$0$0None listed on this filingEDGAR ↗
Oct 20, 2021 D
NeuroFine Corp.
File 021-417668
$0$0$0None listed on this filingEDGAR ↗
Oct 15, 2021 D
Deinde Medical Corp.
File 021-417131
$0$0$0None listed on this filingEDGAR ↗
Sep 8, 2020 D
Prometheus Therapeutics Inc.
File 021-375036
$0$0$0None listed on this filingEDGAR ↗
Nov 27, 2019 D
Deinde Medical Corp.
File 021-354400
$0$0$0None listed on this filingEDGAR ↗
Jun 14, 2017 D
InNeuroCo, Inc.
File 021-288699
$0$0$0None listed on this filingEDGAR ↗
Jun 25, 2015 D
InNeuroCo, Inc.
File 021-242466
$0$0$0None listed on this filingEDGAR ↗
Jan 5, 2015 D
InNeuroCo, Inc.
File 021-231351
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 4

Every issuer that named Ajay Wakhloo on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

Other Health Care · group: Deinde

Prometheus Therapeutics Inc.

Miramar, FL · Sep 8, 2020 → Apr 15, 2026 · 7 filings
  • Apr 15, 2026 · D/A · $2,745,000 sold of $6,500,000 · 13 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Nov 12, 2025 · D · $130,000 sold of $5,000,000 · 3 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Jun 21, 2024 · D/A · $8,182,398 sold of $8,372,387 · 46 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Apr 12, 2024 · D/A · $2,547,453 sold of $8,375,000 · 38 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Feb 13, 2023 · D · $1,052,665 sold of $8,375,000 · 19 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Jul 26, 2022 · D · $345,000 sold of $345,000 · 8 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Sep 8, 2020 · D · $287,107 sold of $697,209 · 7 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $8.18M from 46 investors (100% of the $6.5M target) as of the latest filing. Ajay is listed as executive officer, director on 7 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other Health Care · group: Deinde

NeuroFine Corp.

Miramar, FL · Oct 20, 2021 → Apr 8, 2026 · 5 filings
  • Apr 8, 2026 · D · $1,045,859 sold of $1,045,859 · 14 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Sep 3, 2025 · D · $125,000 sold of $5,000,000 · 2 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Mar 20, 2025 · D · $885,970 sold of $2,000,000 · 12 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Sep 13, 2023 · D · $709,651 sold of $3,951,908 · 16 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 20, 2021 · D · $1,624,048 sold of $1,634,318 · 38 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $1.62M from 38 investors (100% of the $1.05M target) as of the latest filing. Ajay is listed as executive officer, director on 5 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other Health Care · group: Deinde

Deinde Medical Corp.

Miramar, FL · Nov 27, 2019 → Nov 12, 2025 · 5 filings
  • Nov 12, 2025 · D · $185,000 sold of $2,000,000 · 3 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 11, 2025 · D/A · $1,055,000 sold of $2,000,000 · 14 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 9, 2023 · D · $515,000 sold of $1,000,000 · 8 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 15, 2021 · D · $2,533,285 sold of $2,600,000 · 35 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 27, 2019 · D · $2,681,659 sold of $3,000,000 · 29 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $2.68M from 35 investors (100% of the $2M target) as of the latest filing. Ajay is listed as director, executive officer on 5 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other Health Care

InNeuroCo, Inc.

Sunrise, FL · Jan 5, 2015 → Jun 14, 2017 · 3 filings
  • Jun 14, 2017 · D · $800,008 sold of $3,000,030 · 8 investors · min. $100,001 · role: Executive Officer, Director EDGAR ↗
  • Jun 25, 2015 · D · $580,044 sold of $1,500,000 · 8 investors · min. $25,000 · role: Executive Officer, Director EDGAR ↗
  • Jan 5, 2015 · D · $925,000 sold of $1,500,000 · 15 investors · min. $25,000 · role: Executive Officer, Director EDGAR ↗

Raised $925K from 15 investors (31% of the $3M target) as of the latest filing. Ajay is listed as executive officer, director on 3 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

People around Ajay 11

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

ML
No photo found yet (own website and image search run after this page is viewed)
Person

Marc Litzenberg

Executive Officer, Director · 18 shared filings (4 issuers) · also on 1 other issuer

Marc Litzenberg is on 5 issuers in total — a repeat sponsor. Their page lists every one.

JM
No photo found yet (own website and image search run after this page is viewed)
Person

John McEleney

Director · 12 shared filings (4 issuers)

Listed on the same filings as Ajay Wakhloo. Their page shows their other deals.

BN
No photo found yet (own website and image search run after this page is viewed)
Person

Bernie Navarro

Executive Officer · 11 shared filings (3 issuers)

Listed on the same filings as Ajay Wakhloo. Their page shows their other deals.

BL
No photo found yet (own website and image search run after this page is viewed)
Person

Baruch Lieber

Director, Executive Officer · 7 shared filings (1 issuer)

Listed on the same filings as Ajay Wakhloo. Their page shows their other deals.

BN
No photo found yet (own website and image search run after this page is viewed)
Person

Bernardo Navarro

Executive Officer · 6 shared filings (2 issuers)

Listed on the same filings as Ajay Wakhloo. Their page shows their other deals.

DS
No photo found yet (own website and image search run after this page is viewed)
Person

Daniel Sablyak

Director · 5 shared filings (1 issuer)

Listed on the same filings as Ajay Wakhloo. Their page shows their other deals.

PL
No photo found yet (own website and image search run after this page is viewed)
Person

Prattipati Laxminarain

Director, Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as Ajay Wakhloo. Their page shows their other deals.

AH
No photo found yet (own website and image search run after this page is viewed)
Person

Alexander Hastings

Director · 2 shared filings (1 issuer)

Listed on the same filings as Ajay Wakhloo. Their page shows their other deals.

DS
No photo found yet (own website and image search run after this page is viewed)
Person

Dan Sablyak

Director · 2 shared filings (1 issuer)

Listed on the same filings as Ajay Wakhloo. Their page shows their other deals.

DS
No photo found yet (own website and image search run after this page is viewed)
Person

Dan Sabylak

Director · 1 shared filing (1 issuer)

Listed on the same filings as Ajay Wakhloo. Their page shows their other deals.

JH
No photo found yet (own website and image search run after this page is viewed)
Person

Jennifer Halsey

Director · 1 shared filing (1 issuer)

Listed on the same filings as Ajay Wakhloo. Their page shows their other deals.

The team behind the deals

Sponsor group

Deinde

3 issuers · 17 filings · $3.98M reported sold · 2019–2026

One team, 3 deal companies. Ajay Wakhloo is listed on 3 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Ajay Wakhloo.

Registrations and other filings

Adviser registration (Form ADV)

None of the 4 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Ajay Wakhloo by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 4 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Ajay Wakhloo is listed on: none on file. No website or social profile named in Deinde Medical Corp.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #55,001 of 374,652 in line (14 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Miramar, FL). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Ajay Wakhloo appears on a new Form D, or when a court case or SEC action is matched to them. See plans →